Semaglutide, tirzepatide, compounded options, and non-GLP-1 routes when medication isn't the right fit. Sisu coaches the daily habits that make the medication work — or, for the right person, replace it.
Over the last few years, a new class of prescription medications has changed weight management. You may have heard them called “weight-loss injections” or by brand names like Ozempic or Wegovy. The medical term is GLP-1 medications — they work by reducing appetite and helping your body regulate hunger, and they’re prescribed by licensed doctors for people who meet certain criteria (usually a BMI of 30+, or 27+ with a related condition like diabetes or high blood pressure).
You don’t need to understand the science to find out if you’re a candidate. Our free 30-second check tells you where you stand — then, if it makes sense for you, we show you licensed providers who can help.
“If you’ve struggled with weight and wondered whether medication could help — this is where you find out.”
Adults 18+ with BMI ≥27 (plus a qualifying comorbidity like type 2 diabetes, hypertension, sleep apnea, PCOS, or high cholesterol) or BMI ≥30 on BMI alone.
Sisu reads your check-ins, watches the trend, and flags when sleep or stress is dragging weight. The medication is one variable. The daily life around it is everything else — and that's where coaching earns its keep.
Sisu doesn't prescribe medications. When this is the right path for you, we route to US-licensed telehealth providers.
💡 Affiliate disclosure: We may earn a commission when you sign up. This doesn't affect what you pay or our recommendations. Sisu routes based on your state, profile, and provider fit — not commission size.
No. Sisu coaches the full weight-management picture — diet, exercise, sleep, stress. GLP-1 routing only happens if you ask for it and qualify clinically.
Compounded semaglutide or tirzepatide may be available on a patient-specific basis through licensed 503A compounding pharmacies when a licensed provider determines it is appropriate. Compounded medications are not themselves FDA-approved, and the regulatory landscape around compounding is actively changing in 2026. mybmi.ai does not prescribe, sell, or recommend compounded medications — a licensed provider decides what is appropriate for you.
Most affiliate partners are cash-pay. If you have commercial insurance covering GLP-1 for type 2 diabetes, your regular provider is usually the better path. Sisu helps you decide which route to take.
Results vary based on individual medical history, treatment type, dosage, adherence, and provider guidance. Sisu helps you understand your starting point and prepare better questions for a licensed clinician about realistic expectations for your situation.